Skip to main content

Advertisement

SpringerLink
Log in

Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

One in five adults with chronic kidney disease (CKD) in the United States (US) suffers from depression. Comorbid depression in adults with CKD is associated with higher morbidity and mortality. This study used US national survey data to examine patterns and predictors of depression treatment among adults with non-dialysis-dependent CKD in the US.

Methods

A retrospective, cross-sectional study was conducted using 2014–2015 National Ambulatory Medical Care Survey (NAMCS) data. The final study sample consisted of visits by 9.02 million adults (unweighted n = 262; age ≥ 18 years) with CKD and depression in the US. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariable logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors.

Results

Approximately half of adults with CKD and depression received depression treatment. Primary care was the main setting of treatment, and the most commonly prescribed antidepressant class was selective serotonin reuptake inhibitors. Adults being seen for treatment of a chronic problem were 3.2 times more likely to receive depression treatment (OR 3.20; 95% CI 1.38–7.21). In addition, there was a 9% higher likelihood of receiving depression treatment for each unit increase in total number of medications (OR 1.09; 95% CI 1.01–1.19). Finally, adults receiving care in the South were 63% less likely to receive depression treatment (OR 0.37; 95% CI 0.15–0.89).

Conclusions

Depression treatment was recorded in approximately half of US ambulatory care visits involving adults with CKD and depression from 2014 to 2015. Further research is warranted to determine how to appropriately manage treatment of depression in adults with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ (2009) Prevalence of major depressive episode in CKD. Am J Kidney Dis 54(3):424–432. https://doi.org/10.1053/j.ajkd.2009.03.017

    Article  PubMed  PubMed Central  Google Scholar 

  2. Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF (2013) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84(1):179–191. https://doi.org/10.1038/ki.2013.77

    Article  PubMed  Google Scholar 

  3. Lee YJ, Kim MS, Cho S, Kim SR (2013) Association of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney disease. Int J Clin Pract 67(4):363–368. https://doi.org/10.1111/ijcp.12020

    Article  PubMed  Google Scholar 

  4. D’Onofrio G, Simeoni M, Rizza P, Caroleo M, Capria M, Mazzitello G, Sacco T, Mazzuca E, Panzino MT, Cerantonio A, Segura-Garcia C, Andreucci M, De Fazio P, Fuiano G (2017) Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients. Ren Fail 39(1):45–53. https://doi.org/10.1080/0886022X.2016.1244077

    Article  PubMed  Google Scholar 

  5. Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP, Group AS (2011) Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int 80(6):670–678. https://doi.org/10.1038/ki.2011.153

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, Rifkin DE, Sarnak MJ, Gottdiener JS (2011) Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol 6(4):834–844. https://doi.org/10.2215/CJN.03840510

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ (2010) Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 303(19):1946–1953. https://doi.org/10.1001/jama.2010.619

    Article  PubMed  CAS  Google Scholar 

  8. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Hedayati SS, Strippoli GF (2013) Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis 62(3):493–505. https://doi.org/10.1053/j.ajkd.2013.02.369

    Article  PubMed  Google Scholar 

  9. Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC (2012) Association of symptoms of depression with progression of CKD. Am J Kidney Dis 60(1):54–61. https://doi.org/10.1053/j.ajkd.2012.02.325

    Article  PubMed  Google Scholar 

  10. Chiang HH, Guo HR, Livneh H, Lu MC, Yen ML, Tsai TY (2015) Increased risk of progression to dialysis or death in CKD patients with depressive symptoms: a prospective 3-year follow-up cohort study. J Psychosom Res 79(3):228–232. https://doi.org/10.1016/j.jpsychores.2015.01.009

    Article  PubMed  Google Scholar 

  11. Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH (2017) Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial. JAMA 318(19):1876–1890. https://doi.org/10.1001/jama.2017.17131

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Walther CP, Shah AA, Winkelmayer WC (2017) Treating depression in patients with advanced CKD: beyond the generalizability frontier. JAMA 318(19):1873–1874. https://doi.org/10.1001/jama.2017.17553

    Article  PubMed  Google Scholar 

  13. Duarte PS, Miyazaki MC, Blay SL, Sesso R (2009) Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int 76(4):414–421. https://doi.org/10.1038/ki.2009.156

    Article  PubMed  Google Scholar 

  14. Lii YC, Tsay SL, Wang TJ (2007) Group intervention to improve quality of life in haemodialysis patients. J Clin Nurs 16(11C):268–275. https://doi.org/10.1111/j.1365-2702.2007.01963.x

    Article  PubMed  Google Scholar 

  15. Rocha Augusto C, Krzesinski JM, Warling X, Smelten N, Etienne AM (2011) [The role of psychological interventions in dialysis: an exploratory study]. Nephrol Ther 7(4):211–218. https://doi.org/10.1016/j.nephro.2010.12.006

    Article  PubMed  CAS  Google Scholar 

  16. National Centers for Disease Control and Prevention: National Center for Health Statistics. Ambulatory Health Care Data

  17. Survey NAMC (2014) Data documentation. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/doc2014.pdf. Accessed 4 June 2018

  18. Survey NAMC (2015) Data documentation. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/doc2015.pdf. Accessed 4 June 2018

  19. Zenlea IS, Milliren CE, Mednick L, Rhodes ET (2014) Depression screening in adolescents in the United States: a national study of ambulatory office-based practice. Acad Pediatr 14(2):186–191. https://doi.org/10.1016/j.acap.2013.11.006

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hing E, Schappert SM, Burt CW, Shimizu IM (2005) Effects of form length and item format on response patterns and estimates of physician office and hospital outpatient department visits. National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, 2001. Vital Health Stat 2(139):1–32

    Google Scholar 

  21. Anderson JG, Bartkus DE (1973) Choice of medical care: a behavioral model of health and illness behavior. J Health Soc Behav 14(4):348–362

    Article  PubMed  CAS  Google Scholar 

  22. CDC (2015) Reliability of estimates. https://www.cdc.gov/nchs/ahcd/ahcd_estimation_reliability.htm. Accessed 4 June 2018

  23. Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Kurella Tamura M, Kusek JW, Ford V, Rosen LK, Strauss L, Teal VL, Yaffe K, Powe NR, Lash JP, Investigators CSG (2012) Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies. Am J Kidney Dis 60(1):27–38. https://doi.org/10.1053/j.ajkd.2011.12.033

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nagler EV, Webster AC, Vanholder R, Zoccali C (2012) Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant 27(10):3736–3745. https://doi.org/10.1093/ndt/gfs295

    Article  PubMed  CAS  Google Scholar 

  25. Glassman AH, O’Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McLvor M (2002) Sertraline antidepressant heart attack randomized trial. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288(6):701–709

    Article  PubMed  CAS  Google Scholar 

  26. Cohen LM, Tessier EG, Germain MJ, Levy NB (2004) Update on psychotropic medication use in renal disease. Psychosomatics 45(1):34–48. https://doi.org/10.1176/appi.psy.45.1.34

    Article  PubMed  CAS  Google Scholar 

  27. Levy NB, Blumenfield M, Beasley CM Jr, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RR (1996) Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Gen Hosp Psychiatry 18(1):8–13

    Article  PubMed  CAS  Google Scholar 

  28. Atalay H, Solak Y, Biyik M, Biyik Z, Yeksan M, Uguz F, Guney I, Tonbul HZ, Turk S (2010) Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients. Int Urol Nephrol 42(2):527–536. https://doi.org/10.1007/s11255-009-9686-y

    Article  PubMed  CAS  Google Scholar 

  29. Kamo T, Horikawa N, Tsuruta Y, Miyasita M, Hatakeyama H, Maebashi Y (2004) Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis. Psychiatry Clin Neurosci 58(2):133–137

    Article  PubMed  CAS  Google Scholar 

  30. Kalender B, Ozdemir AC, Yalug I, Dervisoglu E (2007) Antidepressant treatment increases quality of life in patients with chronic renal failure. Ren Fail 29(7):817–822. https://doi.org/10.1080/08860220701573517

    Article  PubMed  CAS  Google Scholar 

  31. Kennedy SH, Craven JL, Rodin GM (1989) Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry 50(2):60–63

    PubMed  CAS  Google Scholar 

  32. Lee SK, Lee HS, Lee TB, Kim DH, Koo JR, Kim YK, Son BK (2004) The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients. J Korean Med Sci 19(3):384–389. https://doi.org/10.3346/jkms.2004.19.3.384

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  33. Koo JR, Yoon JY, Joo MH, Lee HS, Oh JE, Kim SG, Seo JW, Lee YK, Kim HJ, Noh JW, Lee SK, Son BK (2005) Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. Am J Med Sci 329(1):1–5

    Article  PubMed  Google Scholar 

  34. Turk S, Atalay H, Altintepe L, Guney I, Okudan N, Tonbul HZ, Gokbel H, Kucur R, Yeksan M, Yildiz A (2006) Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients. Clin Nephrol 65(2):113–118

    Article  PubMed  CAS  Google Scholar 

  35. Blumenfield M, Levy NB, Spinowitz B, Charytan C, Beasley CM Jr, Dubey AK, Solomon RJ, Todd R, Goodman A, Bergstrom RF (1997) Fluoxetine in depressed patients on dialysis. Int J Psychiatry Med 27(1):71–80

    Article  PubMed  CAS  Google Scholar 

  36. Wuerth D, Finkelstein SH, Kliger AS, Finkelstein FO (2003) Chronic peritoneal dialysis patients diagnosed with clinical depression: results of pharmacologic therapy. Semin Dial 16(6):424–427

    Article  PubMed  Google Scholar 

  37. Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF (2016) Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004541.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  38. Shirazian S, Grant CD, Aina O, Mattana J, Khorassani F, Ricardo AC (2017) Depression in chronic kidney disease and end-stage renal disease: similarities and differences in diagnosis, epidemiology, and management. Kidney Int Rep 2(1):94–107. https://doi.org/10.1016/j.ekir.2016.09.005

    Article  PubMed  Google Scholar 

  39. Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL (2007) Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2(6):1332–1342. https://doi.org/10.2215/CJN.03951106

    Article  PubMed  CAS  Google Scholar 

  40. Hedayati SS, Yalamanchili V, Finkelstein FO (2012) A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int 81(3):247–255. https://doi.org/10.1038/ki.2011.358

    Article  PubMed  Google Scholar 

  41. Doyle GD, Laher M, Kelly JG, Byrne MM, Clarkson A, Zussman BD (1989) The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand Suppl 350:89–90

    Article  PubMed  CAS  Google Scholar 

  42. Eyler RF, Unruh ML, Quinn DK, Vilay AM (2015) Psychotherapeutic agents in end-stage renal disease. Semin Dial 28(4):417–426. https://doi.org/10.1111/sdi.12370

    Article  PubMed  Google Scholar 

  43. Anttila SA, Leinonen EV (2001) A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7(3):249–264

    Article  PubMed  CAS  Google Scholar 

  44. Marin H, Menza MA (2005) The management of fatigue in depressed patients. Essent Psychopharmacol 6(4):185–192

    PubMed  Google Scholar 

  45. Foley KF, DeSanty KP, Kast RE (2006) Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother 6(9):1249–1265. https://doi.org/10.1586/14737175.6.9.1249

    Article  PubMed  CAS  Google Scholar 

  46. Angermann CE, Gelbrich G, Stork S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Bohm M, Faller H, Deckert J, Ertl G, Investigators M-HS, Committee M (2016) Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 315(24):2683–2693. https://doi.org/10.1001/jama.2016.7635

    Article  PubMed  CAS  Google Scholar 

  47. O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, Krishnan R, Investigators S-C (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol 56(9):692–699. https://doi.org/10.1016/j.jacc.2010.03.068

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  48. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373(9665):746–758. https://doi.org/10.1016/S0140-6736(09)60046-5

    Article  PubMed  CAS  Google Scholar 

  49. Hedayati SS, Daniel DM, Cohen S, Comstock B, Cukor D, Diaz-Linhart Y, Dember LM, Dubovsky A, Greene T, Grote N, Heagerty P, Katon W, Kimmel PL, Kutner N, Linke L, Quinn D, Rue T, Trivedi MH, Unruh M, Weisbord S, Young BA, Mehrotra R (2016) Rationale and design of A trial of sertraline vs. cognitive behavioral therapy for end-stage renal disease patients with depression (ASCEND). Contemp Clin Trials 47:1–11. https://doi.org/10.1016/j.cct.2015.11.020

    Article  PubMed  Google Scholar 

  50. Blane D, Williams C, Morrison J, Wilson A, Mercer S (2013) Cognitive behavioural therapy: why primary care should have it all. Br J Gen Pract 63(607):103–104. https://doi.org/10.3399/bjgp13X663235

    Article  PubMed  PubMed Central  Google Scholar 

  51. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R (2009) Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4(6):1089–1096. https://doi.org/10.2215/CJN.00290109

    Article  PubMed  PubMed Central  Google Scholar 

  52. Bhattacharjee S, Axon DR, Goldstone L, Lee JK (2018) Patterns and predictors of depression treatment among stroke survivors with depression in ambulatory settings in the United States. J Stroke Cerebrovasc Dis 27(3):563–567. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.047

    Article  PubMed  Google Scholar 

Download references

Funding

This research did not receive any grants from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, 1295 North Martin Avenue, Tucson, AZ, 85721, USA

    Nina Vadiei & Sandipan Bhattacharjee

Authors
  1. Nina Vadiei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandipan Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nina Vadiei.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vadiei, N., Bhattacharjee, S. Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States. Int Urol Nephrol 51, 303–309 (2019). https://doi.org/10.1007/s11255-018-2034-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-2034-3

Keywords

Search

Navigation